Internal Pancreatic Stent
Internal Pancreatic Stent - Related Videos
10:09
Application of Simplified Stent-bridging Pancreaticogastrostomy in Open Pancreaticoduodenectomy
0 Views •
2026
Here, we present the stent-bridging pancreaticogastrostomy (PG) technique, which uses a stent to bridge the remnant pancreas to the stomach during open pancreaticoduodenectomy. The stent-bridging PG aims to simplify the anastomosis, achieve complete diversion of pancreatic juice, and minimize manipulation of the pancreatic remnant.
05:37
Human Internal Mammary Artery (IMA) Transplantation and Stenting: A Human Model to Study the Development of In-Stent Restenosis
0 Views •
Cited by 5 •
2012
This video shows a model to study the development of intimal hyperplasia after stent deployment using a human vessel (IMA) in an immunodeficient rat model.
06:55
Fabrication of Small Caliber Stent-grafts Using Electrospinning and Balloon Expandable Bare Metal Stents
0 Views •
Cited by 10 •
2016
In the protocol, we present a method to manufacture a small caliber stent-graft by sandwiching a balloon expandable stent between two electrospun nanofibrous polyurethane layers.
05:11
Treatment of Middle-segment Pancreatic Benign Tumor Using Laparoscopic Central Pancreatectomy with End-to-end Pancreatic Duct Reconstruction
0 Views •
2026
This article presents laparoscopic central pancreatectomy with pancreatic duct end-to-end anastomosis as an important surgical approach for middle-segment pancreatic benign and low-grade malignant tumors.
04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
0 Views •
Cited by 11 •
2013
A model of stent implantation in mouse carotid artery is described. Compared to other similar methods, this procedure is very rapid, simple and accessible, offering the possibility to study in a convenient way the vascular wall reaction to different drug-eluting stents and the molecular mechanisms of restenosis.
FAQs
Its main effect is to preserve a passage through a duct segment whose drainage has been impaired. By providing an open lumen across the affected area, the device supports movement of pancreatic secretions and reduces the contribution of duct blockage to obstruction-related complications. This makes duct patency a central outcome when evaluating stent performance.
Spanning the affected segment places the stent’s open pathway across the site where disease or intervention disrupts drainage. Structural support helps prevent that section from remaining functionally closed, while the lumen provides continuity for secretions. This positioning principle is important when researchers compare placement strategies or examine how effectively a device addresses localized obstruction.
The lumen supplies the internal route for pancreatic secretions, while the surrounding structure helps maintain duct openness across a narrowed or obstructed region. These functions address different aspects of impaired drainage but operate together. Studies of stent design can therefore assess both the pathway available for flow and the support needed to preserve that pathway.
Tumors may impair duct drainage by compressing or invading the pancreatic duct. That relationship gives cancer researchers a model for examining obstruction-related complications and the effects of procedural management. It also connects stent evaluation with patient outcomes, because maintaining duct patency can be studied alongside the consequences of tumor-associated blockage.
Placement may be performed endoscopically or surgically, depending on the intervention being studied. In either pathway, the procedure positions the device across the narrowed or obstructed duct segment so its lumen and structural support can assist drainage. Comparing these placement strategies can help investigators examine procedural management and the resulting outcomes in pancreatic disease.
Temporary devices are not necessarily left in place indefinitely; they may later be removed or exchanged. This makes follow-up management part of the stenting strategy rather than a separate consideration. Research can therefore address not only initial placement, but also how device duration and subsequent management relate to maintaining duct drainage and supporting treatment.
These studies can investigate how duct obstruction relates to pancreatic tumors, which complications arise when drainage is impaired, and how procedural management affects patient outcomes. They also provide a practical setting for evaluating stent design and placement strategies. Together, these areas connect device research with supportive care for cancer-associated pancreatic duct obstruction.